期刊文献+

sLRIG1蛋白多克隆抗体的制备及鉴定

Preparation and identification of the polyclonal antibody to soluble leucine-rich repeats and immunoglobulin-like domains 1
暂未订购
导出
摘要 目的制备专门针对富含亮氨酸重复区免疫球蛋白样蛋白1(LRIG1)胞外段(或称可溶性LRIG1,sLRIG1)抗体。方法人工设计、合成sLRIG1抗原多肽,免疫日本大耳朵白兔,颈动脉取血,分离兔血清;酶联免疫吸附分析法测定抗体效价,免疫印迹鉴定所获抗体。结果抗sLRTG1抗体滴度可高达1:512000;免疫印迹证实所获抗体能与sLRIG1特异性结合,在100kD处蛋白显影清晰。结论成功获得兔抗人sLRIG1多克隆抗体,可满足进一步研究的需要。 Objective To obtain the good quality antibody to the soluble leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1). Methods The ectodomains, i.e. soluble LRIG1 (gene No. AF381545), which were designed and synthesized in vitro, were intracutaneously injected in Japanese white rabbits. The antibodies which were obtained from the immunized rabbits' serum were purified. The obtained antibodies were identified by SDS-PAGE and western blotting. The titre of the antibodies was measured by enzyme-linked immunoassay. Results The antibodies which could specifically bind to the soluble LRIG1 were successfully^obtained. There was a clear protein blot around 100 kD on the western film as expected. The titre of the antibodies was high as 1 : 512 000. Conclusion The polyclonal antibodies to soluble LRIG1 which were successfully obtained may satisfy the needs of the further experimental research.
出处 《中国临床神经外科杂志》 2012年第12期743-745,共3页 Chinese Journal of Clinical Neurosurgery
基金 国家自然科学基金资助项目(30973073 81172402) 教育部新教师基金(200804861039)
关键词 富含亮氨酸重复区免疫球蛋白样蛋白1(LRIG1) 可溶性LRIG1 多克隆抗体 抗体制备 鉴定 Soluble leucine-rich repeats and immunoglobulin-like domains 1 Polyclonal antibody Preparation Identification
  • 相关文献

参考文献14

  • 1Gur G, Rubin C, Katz M, et al. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degra- dation [J]. EMBO J, 2004, 23(16): 3270-3281.
  • 2Shattuck DE, MilLer .IK, Laederich M, et al. LRIG1 is a novel negative regulator of the Met receptor and opposes Met andHer2 synergy [J]. Mol Cell Biol, 2007, 27(5): 1934-1946.
  • 3Ledda F, Bieraugel O, Fard SS, et al. LRIG1 is an endoge- nous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF [J]. J Neurosci, 2008, 28(1): 39-49.
  • 4Nilsson J, Vallbo C, Guo D, et al. Cloning, characterization, and expression of human LR1G1 [J]. Biochem Biophys Res Commun, 2001, 284:1155-1161.
  • 5Sathornsumetee S, Reardon DA, Desjardins A, et al. Mole- cularly targeted therapy for malignant glioma [J]. Cancer, 2007, 110(1): 13-24.
  • 6Omuro AM, Faivre S, Raymond E. Lessons learned in the development of targeted therapy for malignant gliomas [J]. Mol Cancer Ther, 2007, 6(7): 1909-1919.
  • 7Yi W, Ye F, Guo D, et al. Expression of leucine-rich repeats and immunoglobulin-like domains(LRIG) proteins in human astrocytomas [J]. Chin-Ger J Clin Oncol, 2005, 4(4): 225- 228.
  • 8Hedman H, Henriksson R. LRIG inhibitors of growth factor signalling- double-edged swords in human cancer [J]? Eur J Cancer, 2007, 43(4): 676-682.
  • 9Hedman H, Nilsson J, Guo D, et al. Is LRIG1 a tumour sup- pressor gene at chromosome 3p14.3 [J]? Acta Oneol, 2002, 41(4): 352-354.
  • 10易伟,叶飞,郭东升,薛德麟,雷霆.LRIG1基因在人星形细胞瘤中的表达与意义[J].中国临床神经外科杂志,2006,11(1):29-31. 被引量:7

二级参考文献24

  • 1易伟,叶飞,郭东升,薛德麟,雷霆.LRIG1基因在人星形细胞瘤中的表达与意义[J].中国临床神经外科杂志,2006,11(1):29-31. 被引量:7
  • 2Nilsson J, Vallbo C, Guo D, et al . Cloning, characterization, and expression of human LIGI [J]. Biochem Biophys Res Commun, 2001, 284(5): 1155-1161.
  • 3Hedman H, Nilsson J, Guo D, Henriksson R. Is LRIG1 a tumour suppressor gene at chromosome 3p14.3 [J]? Acta Oncol, 2002, 41(4): 352-354.
  • 4Kleihues P, Louis DN, Scheithauer BW, et al . The WHO classification of tumors of the nervous system [J]. J Neuropathol Exp Neurol, 2002, 61(3): 215-229.
  • 5Musacchio M, Perrimon N. The Drosophila kekkon genes:novel members of both the leucine-rich repeat and immunoglobulin superfamilies expressed in the CNS. Dev Biol,1996, 178(1): 63-76.
  • 6Suzuki Y, Sato N, Tohyama M, et al . cDNA cloning of a novel membrane glycoprotein that is expressed specifically in glial cells in the mouse brain. LIG-1, a protein with leucine-rich repeats and immunoglobulin-like domains [J].J Biol Chem, 1996, 271(37): 22522-22527.
  • 7Maga G, Hubscber U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners [J]. J Cell Sci, 2003, 116(Pt15): 3051-3060.
  • 8Ghiglione C, Canaway KL 3rd, Amundadottir LT, et al, .The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis [J]. Cell, 1999, 96(6): 847-856.
  • 9Mukohara T, Kudoh S, Yamauchi S, et al . Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC) [J]. Lung Cancer, 2003, 41(2): 123-130.
  • 10Mimeault M, Pommery N, Henichart JP. New advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system [J]. Growth Factors, 2003,21(1): 1-14.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部